Name & Company Information Location Interests Events
user-icon

Rebecca Abbott

March of Dimes

Director, Public Policy

Washington

United States

New Hope, Big Challenges: Newborn Screening in the Genetic Era
user-icon

Mr. Reza Afkhami

Surrozen

VP Corporate Development and Strategy

South San Francisco

United States

-
RBP_2011-Edit

Gautam Aggarwal

Triangle Insights Group, LLC

Partner

Durham

United States

Drug>Clinical, Drug>Market - Drug (on Patent), Interest Area>Biologics, Interest Area>Business Development & Finance, Interest Area>Gene Editing, Interest Area>Gene/Cell Therapy, Interest Area>Metabolic Diseases, Interest Area>Oncology, Interest Area>Value, Investor>VC/PE, Service>Consulting, Session Tracks>Business Development & Finance, Session Tracks>Genome Editing, Session Tracks>Oncology, Session Tracks>Value‚ Patient Access‚ & Reimbursement -
user-icon

Samuel Agresta

Infinity Pharmaceuticals

Chief Medical Officer

Cambridge

United States

What Was Hot at ASCO 2019? Highlights from the World’s Biggest Oncology Meeting
user-icon

Dr. Andrew Aherrera

Cugene Inc.

Head of Business Development

Waltham

United States

Cugene Inc. Company Presentation
user-icon

Mr. Jaeyoung Ahn

Voronoi

Head of BD

Incheon

Korea, Republic of

VORONOI Inc. Company Presentation
545055-9fecb268-4303-4a8a-bf1c-dfb208ec3e81

Murray Aitken

IQVIA Institute for Human Data Science

Executive Director

New York

United States

Opioids: Changing the paradigm of treating pain and addiction - one year later, Biotech’s Contribution to Innovation: Current and Future Drivers of Success, Closing the Innovation Gap in Rare Diseases: Where are we Headed?
user-icon

Amirah Al Idrus

FierceBiotech

Editor

Washington

United States

How Could AI Help Cure Cancer in the Next Five Years?
2TMTeBD

Ms. Lisa Alderson

Genome Medical

Co-founder and CEO

South San Francisco

United States

Genome Medical Company Presentation
544193-07f79335-d052-4d7b-9d3f-764423bf635c

Dr. Wendy Alderton

Cambridge University, UK

Cancer Research UK Cambridge Centre Early Detection Programme Manager

Cambridge

United Kingdom

Climbing Cancer’s North Face: The Challenges of Developing and Clinically Validating Biomarkers for Early Cancer Detection
BioPro_Logo_rgb

Jim Alferman

Sekisui

Associate Director, Business Development

Maidstone

United Kingdom

BioPharma/Human Health>Therapeutics Biologics, BioPharma/Human Health>Vaccines, Management Level>Director/Mid-Level Manager, Microbial, North America>United States, Outsourcing, Primary Role>Business Development, Program Interest>General Biotechnology Interest, Program Interest>Next Generation Biotherapeutics, Western Europe>U.K., Interest Area>Cell Biology, Interest Area>Diagnostics, Interest Area>Next Generation Bioetherapeutics, Interest Area>Partnering, Session Tracks>Next Generation Biotherapeutics Sekisui Company Presentation
user-icon

Brandon Allgood

Numerate

CTO

San Francisco

United States

The Hype, the Promise and the Reality of Artificial Intelligence in Personalized Medicine
user-icon

Cambria Alpha-Cobb

Momenta Pharmaceuticals

Patent Agent

Boston

United States

Don’t Be Barred by the On-Sale Bar: Helsinn and Other Case Updates
395419

Dr. Michael Altorfer

Swiss Biotech Association

CEO

Zürich

Switzerland

Switzerland - Global Innovation Hub
user-icon

David Anderson

Spark Therapeutics

CNS Research Lead

Complex CNS diseases: The Next Frontier in AAV Gene Therapy
544533-bea5e4d9-8cb9-4652-b03d-3037d009edd5

Mr. Django Andrews

Sarepta Therapeutics, Inc.

Director, Sr. Patent Counsel

Cambridge

United States

Ready to Launch? IP Strategies for Emerging Pharma and Biotech Companies Navigating Regulatory Approval
613704-58db9718-4867-4ece-b5e4-8eb5ce708877

Christopher Anselmo

Muscular Dystrophy Association

Market Intelligence Manager

Westbrook

United States

Job Function>Not-for-Profit, Job Level>Manager, Job Level>Volunteer / Student Understanding the Voices of Patients: Unique Perspectives on Healthcare
user-icon

John Armando

Biogen

Manager, Global Regulatory Affairs CMC

Regulatory Interactions and Opportunities at the Forefront of Innovative Manufacturing
userPhoto

Fredrik Aslund

European Patent Office

Team Manager

Munich

Germany

Netherlands Pitfalls for US Applicants When Filing Patent Applications at the EPO
user-icon

Anil Asnani

Labcorp

VP

Burlington

United States

How Can Biopharma Divest to Innovate?